StemCell Therapy

Two Charlotte veterinarians say getting your pet vaccinated for COVID-19 isn't an option right now but interest is growing.

CHARLOTTE, N.C. A recent article from the New York Post about dogs and cats possibly needing the COVID-19 vaccine has pet owners talking on social media.

With vaccine supplies in short supply, some people are wondering when their pet would be eligible for a vaccine, if it's safe or whether they need it at all.

As Wake Up Charlotte viewers know, our pets are a big part of our lives, as well as our viewers. So, WCNC Charlotte's Rachel Lundberg went to two Charlotte veterinarians to get the answers.

So, do our dogs and cats need to be vaccinated for COVID-19? Here's what we learned after talking to two Charlotte veterinarians.

Marnie Gallagher, doctor of veterinarian medicine, at Armstrong Animal Clinic and Dr. Fred Wininger, a neurologist neurosurgeon at Charlotte Referral and Emergency, agreed that household pets are not a big concern for either suffering severe illness or spreading the virus that causes COVID-19.

"There have been no cases where an animal, specifically dog and cat, has transmitted it back to people," Wininger said. "...and then also, animals that do get infected, which is rare, are often asymptomatic."

For the cases confirmed in animals, the American Veterinary Medical Association (AVMA) tracks each diagnosis through an interactive map, which shows one case in South Carolina and two in North Carolina over the course of this pandemic.

"The one in North Carolina was last July, and it was a house dog, then there was a dog last November that was in a shelter situation," Gallagher said.

But even though the numbers are low, there is *interest*in potentially vaccinating our pets for COVID-19 down the road, especially following outbreaks detected in minks, which the New York Post also wrote about.

Enough *interest* that there are some companies that are looking at developing vaccines, Gallagher says.

"More for the big cats and minx than anything else, but none have been approved by the USDA," she added.

So, at this time, dogs and cats cannot get the COVID-19 vaccine, nor is it believed necessary.

"It is likely safe on most animals, but the efficacy of it in animals is unknown, and no dog or cat has died from the virus," Wininger said.

To read more about what the CDC says regarding COVID-19 and animals, click here.

Go here to read the rest:
Do pets need to get the COVID-19 vaccine? - WFMYNews2.com

Researchers evaluated 17 widely available over-the-counter brands.

Getty Images

A team of researchers, led by a Texas A&M University professor, has found that some energy drinks have adverse effects on the muscle cells of the heart.

The study, led byDr. Ivan Rusyn, a professor in theVeterinary Integrative Biosciences (VIBS) Department at the Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVMBS), was published in Food and Chemical Toxicology. In it, researchers observed cardiomyocytes human heart cells grown in a laboratory exposed to some energy drinks showed an increased beat rate and other factors affecting cardiac function.

Dr. Ivan Rusyn

Texas A&M College of Veterinary Medicine & Biomedical Sciences

When placed in the context of the human body, consumption of these beverages has been linked to improper beating of the heart, cardiomyopathy (disease of the heart muscle which makes it difficult for the heart to pump blood), increased blood pressure, and other heart conditions.

With the global sales of energy drinks estimated at $53 billion in 2018 and rapidly growing, it is important to understand the potential unintended health consequences associated with these beverages, according to Rusyn.

Because the consumption of these beverages is not regulated and they are widely accessible over the counter to all age groups, the potential for adverse health effects of these products is a subject of concern and needed research, Rusyn said. Indeed, the consumption of energy drinks has been associated with a wide range of adverse health effects in humans, many of them are concerning the effects on the heart.

Researchers evaluated 17 widely available over-the-counter brands. They then treated cardiomyocytes with each drink.

Researchers also studied the composition of the energy drinks using novel methods. By comparing the effects and differing ingredient concentrations in each drink, they were able to infer which ingredients may be contributing more to adverse effects on the treated cardiomyocytes. Using mathematical models, researchers determined that the possible presence of theophylline, adenine and azelate, substances which can have negative effects on the heart.

Little is known about the ingredients that may contribute to the adverse effects of energy drinks on the heart, Rusyn said. Specifically, the evidence for cardiovascular effects from studies in humans remains inconclusive, as the controlled clinical trials were largely limited in the number of participants. They were tested only a limited number of energy drink types, and are difficult to compare directly, because they employed different methods to evaluate the function of the cardiovascular system.

Further research is warranted on the ingredients identified in this study to ensure the safety of their consumption, especially by consumers with pre-existing health conditions.

This study shows that some of the tested energy drinks may have effects on human cardiomyocytes, and these data corroborate other studies in humans, Rusyn said. Therefore, we hope that the consumers will carefully weigh the performance-enhancing benefits of these beverages versus the emerging data that suggests that they may have real adverse effects.

We also hope that the Food and Drug Administration takes a closer look at whether these beverages may need to be carefully reviewed with respect to possible labeling of their adverse health effects, and whether certain age groups and susceptible sub-populations should be advised against consumption of these beverages.

Read the original:
Texas A&M Researchers Discover Energy Drinks' Harmful Effects On Heart - Texas A&M University Today

Kortny Hahn|Cheboygan Daily Tribune

The Feb. 10 meeting of the Straits Area Audubon Society beginning at 7 p.m. will feature a presentation by Dr. Carl Palazzolo regarding medical care of wild birds.

This presentation is being done online, via Zoom, in order to allow members and others interested in the presentation to remain safe in their homes during the pandemic, while learning some new information. It is free and open to the public, with the link to the meeting being posted at http://www.straitsareaaudubon.com.

"Presenter Dr. Carl Palazzolo has served with the Long Beach Animal Hospital in California since graduating from Michigan State University Veterinarian School in 1978," said Jim Bricker of Straits Area Audubon Society. "Dr. Palazzolo spends summers near Harbor Springs."

Bricker said Palazzolo has been giving talks for several decades, all of which have been entertaining, informative and also sprinkled with some humor.

When Palazzolo is in Northern Michigan, he hosts veterinarian training programs to help new veterinarians gain experience and confidence in the growing field of wildlife care. His presentation will feature a behind-the-scenes view of providing medical care for injured wildlife and exotic animals, especially birds.

During his career, he has also donated his time for birds and other wild animals and taking care of them. He has also lead several trips to countries like Tsavo and Borneo to look at other wildlife such as lions and orangutans.

"His stories and examples will include the diagnosis, treatment, and release of a barn owl that was hanging by its wing under an overpass, a red-tailed hawk with a fractured wing, and repairing an injured eye on an owl. We are super excited to host him all the way from California," said Herm Boatin, Straits Area Audubon Society president.

The program will cover substantial medical information that is seldom available to the public. Some of the photos are graphic in nature because they are taken from actual surgical procedures.

Besides the general public who care about animals, the presentation is ideal for budding wildlife rehabbers and students who want to learn more about wildlife and veterinary medicine," said Boatin.

It is the goal of the Straits Area Audubon Society to educate the public about the natural environment. Normally, the monthly meetings of the group are hosted at the Cheboygan Area Public Library, in the downstairs meeting room. Due to the COVID 19 pandemic, the meetings have switched online, via Zoom.

More information on the Straits Area Audubon Society and the link to the program can be found at its website, http://www.straitsareaaudubon.com.

For more information on the presenter, Palazzolo, visit https://www.lbah.com/wildlife-care/. You can also click on the wildlife photography link on that site to learn more about his digital photography.

Carl Palazzolo will be the presenter at the Feb. 10 Straits Area Audubon Society online meeting, discussing the medical care of wild animals and birds. Courtesy photo

SEO Warning

Layout Priority

See more here:
Online presentation to discuss medical care of wild birds - Cheboygan Daily Tribune

Q: My neighbor's healthy young dog died suddenly of liver failure. The vet thinks the cause was aflatoxins in a new bag of dog food, since the food was later recalled. How can I prevent something similar from happening to my dog?

A: Aflatoxins are poisons produced by molds, particularly Aspergillus molds, that grow on grains such as corn and rice, as well as soybeans, tree nuts, peanuts and cottonseeds. These molds flourish under warm, moist growing and storage conditions.

Aflatoxins are not affected by heat, so they persist after food is processed. In December and January, Midwestern Pet Food recalled its Sportmix, Sportstrail, Nunn Better, Pro Pac and Splash pet foods after many dogs became ill or died after eating it, and testing showed very high levels of aflatoxins in the food.

In September and October, Sunshine Mills cited high aflatoxin levels when they recalled 17 brands of pet food.

While aflatoxins harm many animal species, dogs, especially puppies, are particularly sensitive.

Depending on how much aflatoxin is ingested, a dog can experience liver damage (even without clinical signs), liver failure or death. Aflatoxin exposure also causes liver cancer.

Signs of liver damage include decreased appetite and energy, regurgitation, diarrhea and jaundice, indicated by yellowing of the eyes, gums and skin. Clinical signs can begin within a day or two of ingestion or be delayed for weeks.

To protect your dog, buy pet food from large, well-established manufacturers with on-staff veterinary nutritionists who test the products in dogs. Ask your veterinarian for recommendations.

Store pet food in a clean, dry, cool place. Although most aflatoxin-tainted food doesn't show visible mold, don't feed moldy food or any food your dog suddenly dislikes, especially if it's from a new bag.

Never let your dog munch on livestock feed, because regulatory agencies permit aflatoxin levels to be 15 times higher in livestock feed than in pet food.

Q: A year ago, my wife took in Nugget, a stray kitten with long hair. My wife has obsessive-compulsive disorder, which manifests as compulsive housecleaning.

Because Nugget drops hair everywhere she goes, my wife locks her in a carrier 20 hours of every day. For the remaining few hours, Nugget is confined in one room to eat, drink and use the litter box.

We have a large house that I'm certain Nugget would enjoy exploring. It's too risky to let her go outdoors because of the predators in our rural area. I'd appreciate any ideas to persuade my wife to give Nugget the run of the house.

A: I'll begin by suggesting your wife consult her therapist about how her obsessive-compulsive disorder is affecting Nugget. Cognitive behavioral therapy, medication and other treatments can help.

Confining Nugget to a carrier most of each day is not only inhumane but can also contribute to a variety of health problems. For example, forcing her to hold her bladder all day increases her risk of urinary disease.

You can help by brushing Nugget daily, which should decrease the amount of hair around your home. Having her shaved also will decrease the volume of fur she sheds.

Fleas increase shedding, so make sure Nugget is treated throughout the year with a flea preventive. If she's shedding so much that her hair is sparse, make an appointment with her veterinarian.

If your wife remains unwilling to release Nugget from confinement, consider giving her to a family looking for an indoor cat to play throughout their home and snuggle with family members.

I'm certain your wife shares your desire to do what's best for Nugget. But you will have to take a stand to make that happen. Best wishes to all three of you.

Lee Pickett, VMD, practices companion animal medicine in North Carolina. Contact her at

vet@askthevet.pet

More here:
Dog food recall cites trace of deadly toxins - Arkansas Online

SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc.. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based on a novel nanomedicines platform has announced today that its broad-spectrum anti-coronavirus drug candidate for the treatment of COVID-19 infections was well tolerated in safety pharmacology studies required for progressing to human clinical trials.

The Company reports that its drug candidate NV-CoV-2 was found to be safe in the GLP safety pharmacology studies performed by an external contract research organization (CRO) in both rat and non-human primate (NHP) models. Additionally, multiple injections of NV-CoV-2 were also well tolerated in an extensive non-GLP study in rats that was performed by AR Biosystems, Inc., FL.

Based on the safety of NV-CoV-2 in these studies, the Company believes that projected dosages would be safe in human clinical trials. With these findings, the Company believes that it will be possible to administer repeated dosages of NV-CoV-2 in a human clinical trial, if needed, to achieve control over the coronavirus infection from SARS-CoV-2 or its variants.

In a GLP neuro-pulmonary safety pharmacology study in rats, the following conclusion was drawn: The intravenous administration of NV-CoV-2 at doses of 25, 50 and 100 mg/kg did not affect respiratory function in rats.

In a GLP cardiovascular function study in the NHP cynomolgus monkeys, the following conclusion was drawn: Intravenous infusion of NV-CoV-2 at 25, 37.5, and 50 mg/kg did not have any toxicologic effects on cardiac rhythm or ECG morphology in cynomolgus monkeys in this study. No significant effects on blood pressure and heart rate were observed after the intravenous infusion of NV-CoV-2.

These results were consistent with a more extensive, multiple injection non-GLP safety and tolerability study in Sprague-Dawley male and female rats. In this non-GLP study, NV-CoV-2 was injected intravenously (via tail vein) on each of days 0, 1, 2, 3, 4, and 5. Two different doses were used: 320mg/kg BW per injection, and 160 mg/kg BW per injection. Clinical observations, body weight, urine, blood chemistry, post-mortem findings, and organ histology were studied. In all parameters, NV-CoV-2 was well tolerated at both dosages throughout the study.

The Company has received draft reports from all of these studies. We anticipate receiving final audited reports on the GLP studies shortly.

The Company is preparing to submit a pre-IND application to the US FDA with safety tolerability and effectiveness data to obtain guidance regarding human clinical trials. Additionally, we are actively seeking opportunities to engage appropriate sites for human clinical trials. Further, we are engaged in the preparation of clinical trial protocols and other activities that would be necessary for submitting an IND application to the US FDA.

The need for the broad-spectrum, pan-coronavirus nanoviricide drug treatment cannot be overstated for combating the COVID-19 pandemic given the current circumstances and the present status of the pandemic. New virus variants continue to develop in the field. The variants that have advantages in terms of transmissibility, infectivity, and escape from drugs and vaccines will continue to evolve and spread, replacing prior variants. This is already well documented.

Several vaccines have been found to be substantially less effective in protecting against infection by the South African variant, N501Y-V.2 (also called lineage B.1.351) than the earlier variants. A mutation present in B.1.351 as well as Brazilian variant P.1 that is thought to be possibly linked to evasion from antibody drugs and vaccines, E484K, has also been reported in UK in a further differentiated mutant of the variant of concern lineage B.1.1.7. The available monoclonal antibody drugs and convalescent plasma antibodies have been reported to be less effective against several variants.

By the very nature of how they work, vaccines and antibodies tend to be highly specific to the target virus variant, and do not afford strong protection against differentiated variants that are evolutionary distant from the target variant. This scientific fact is now well demonstrated for the COVID-19 pandemic.

It is therefore clear that an effective broad-spectrum anti-coronavirus drug will be needed before the world can return to normal activity.

The Company previously had advanced NV-CoV-1 and had continued to work further with additional drug candidates. One of these drug candidates, namely, NV-CoV-2 was found to have several advantages over NV-CoV-1 in terms of manufacturability and dose formulation. Therefore the Company has advanced NV-CoV-2 into GLP safety/pharmacology studies.

NanoViricides is developing a broad-spectrum antiviral drug where the potential for escape of virus variants is minimized by the very design of the drug for the treatment of COVID-19 infected sick persons. In contrast, vaccines are not treatments for sick persons, and must be administered to healthy individuals, and further require several weeks for the recipient's immune system to become capable of protecting against the target virus strain which still may not protect against new virus variants circulating by that time.

NanoViricides has a strong advantage in that the Company has its own cGMP-capable manufacturing facility in Shelton, CT. This facility is capable of producing approximately 4kg of the COVID-19 drug per batch. We anticipate that this would be sufficient for human clinical trials, and possibly for initial introduction under Compassionate Use, Emergency Use Authorization or similar regulatory approval.

"We are pleased with the results of the safety pharmacology studies, and now we are confident that our COVID-19 drug candidate can advance into human clinical trials," said Anil R. Diwan, PhD, President and co-Founder of NanoViricides, Inc., and co-Inventor of its platform technologies and drug candidates.

About NanoViricides

NanoViricides, Inc. (the "Company")(www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. In addition, we are developing a clinical candidate for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. The Company cannot project an exact date for filing an IND for this drug because of its dependence on a number of external collaborators and consultants.

The Company is now working on tasks for completing an IND application. The Company is currently pursuing two separate drug candidates for the treatment of COVID-19 patients. NV-CoV-2 is our nanoviricide drug candidate that does not encapsulate remdesivir. NV-CoV-2-R is our other drug candidate that is made up of NV-CoV-2 with remdesivir encapsulated in it. The Company believes that since remdesivir is already US FDA approved, our drug candidate encapsulating remdesivir is likely to be an approvable drug, if safety is comparable. Remdesivir is developed by Gilead. The Company has developed both of own drug candidates NV-CoV-2 and NV-CoV-2-R independently.

The Company intends to re-engage into an IND application to the US FDA for NV-HHV-101 drug candidate for the treatment of shingles once its COVID-19 project moves into clinical trials, based on resources availability. The NV-HHV-101 program was slowed down because of the effects of recent COVID-19 restrictions, and re-prioritization for COVID-19 drug development work.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides' platform technology and programs are based on the TheraCour nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus and Ebola/Marburg viruses. The Company has executed a Memorandum of Understanding with TheraCour that provides a limited license for research and development for drugs against human coronaviruses. The Company intends to obtain a full license and has begun the process for the same. The Company's technology is based on broad, exclusive, sub-licensable, field licenses to drugs developed in these areas from TheraCour Pharma, Inc. The Company's business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company's pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.

FDA refers to US Food and Drug Administration. IND application refers to "Investigational New Drug" application. cGMP refers to current Good Manufacturing Practices. CMC refers to "Chemistry, Manufacture, and Controls". CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency's (EMA) committee responsible for human medicines.

Contact:NanoViricides, Inc.info@nanoviricides.com

Public Relations Contact:MJ ClyburnTraDigital IRclyburn@tradigitalir.com

SOURCE: NanoViricides, Inc.

View source version on accesswire.com:https://www.accesswire.com/628273/NanoViricidess-Broad-Spectrum-Antiviral-Drug-Candidate-for-the-Treatment-of-COVID-19-Infections-was-Well-Tolerated-in-GLP-and-non-GLP-Animal-Safety-Studies

View post:
NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety...

The Global Nanorobots In Blood Market Research Report Forecast 2021-2028 is a valuable source of insightful data for business strategists. It provides the Nanorobots In Blood industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Nanorobots In Blood market study provides comprehensive data which enhances the understanding, scope and application of this report.

Request a Free sample Copy of this premium https://www.qyreports.com/request-sample/?report-id=193594

Key Players:

Nanorobots In Blood Market Segment by Solution Type, covers:

Nanorobots In Blood Market Segment by Application, covers:

Key Benefits

The report provides a qualitative and quantitative analysis of the current Nanorobots In Blood Market trends, forecasts, and market size from 2021 to 2028 to determine the prevailing opportunities. Porters Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry. Top impacting factors & major investment pockets are highlighted in the research. The major countries in each region are analysed and their revenue contribution is mentioned. The Nanorobots In Blood Market report also provides an understanding of the current position of the market players active in the small satellite industry.

The report begins with a brief introduction and Nanorobots In Blood market overview of the Nanorobots In Blood industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed, along with current trends and policies in the industry.

Request a discount on standard prices of this premium research https://www.qyreports.com/ask-for-discount/?report-id=193594

The report provides a detailed study of the growth rate of every segment with the help of charts and tables. Furthermore, various regions related to the growth of the market are analysed in the report.

Global Nanorobots In Blood Market: Regional Segment Analysis

Besides this, the research demonstrates the growth trends and upcoming opportunities in every region.

Analysts have revealed that the Nanorobots In Blood Market has shown several significant developments over the past few years. The report offers sound predictions on market value and volume that can be beneficial for the market players, investors, stakeholders, and new entrants to gain detailed insights and obtain a leading position in the market.

Additionally, the report offers an in-depth analysis of key market players functioning in the global Nanorobots In Blood industry.

Furthermore, it throws light on key business priorities in order to assist the companies. The global Nanorobots In Blood Market report summarized with different case studies from leading industries, policymakers, business owners, and industry experts. The growth predictions for numerous segments have been included in the report.

Reasons for Buying this Report:

Enquiry Before Buying https://www.qyreports.com/enquiry-before-buying/?report-id=193594

About QYReports:

We at QYReports, a leading market research report publisher cater to more than 4,000 prestigious clients worldwide meeting their customized research requirements in terms of market data size and its application. Our list of customers include renowned Chinese companys multinational companies, SMEs and private equity firms. Our business study covers a market size of over 30 industries offering you accurate, in depth and reliable market insight, industry analysis and structure. QYReports specialize in forecasts needed for investing in and execution of a new project globally and in Chinese markets.

Contact Us:

Name: Jones John

Contact number: +1-510-560-6005

204, Professional Center,

7950 NW 53rd Street, Miami, Florida 33166

sales@qyreports.com

http://www.qyreports.com

Read this article:
Nanorobots In Blood Market Top-Vendor And Industry Analysis By End-User Segments Till 2028 | Aries Chemical, GE Water & Process Technologies KSU...

Janelle Overhouse and her dog Rory, a patient at Texas A&Ms Veterinary Medical Teaching Hospital.

Michael Kellett/Texas A&M College of Veterinary Medicine & Biomedical Sciences

Doctors at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences (CVMBS) Veterinary Medical Teaching Hospital (VMTH) were recently confronted with a big problem how to save a dog from a first-of-its-kind critical illness.

First, the six-year-old boxer named Rory was infected by a rare form of Salmonella that has never before been seen in a dog. And second, her Salmonella infection was the first to be found in a dogs brain.

Rorys story begins long before her infection. She first became a patient when she was diagnosed with a common, but serious, form of meningitis when she was a year old.

During her first visit to the VMTH in 2015, Rory was diagnosed with Steroid Responsive Meningitis-Arteritis (SRMA), an immune-mediated inflammatory disease common in boxers that can cause neck pain and fever.

Id never even heard of SRMA and didnt know anything about it, said Rorys owner Janelle Overhouse. Once I learned more, I found that it was something that could be chronic. That was really scary, because she was in a tremendous amount of pain.

Luckily, Rorys form of SRMA could be treated with a few months of immunosuppressive steroids that, when finished, allow the dog to return to a completely normal life. While SRMA tends to repeatedly flare up over the years, it can usually be treated the same way with minimal complications.

For some patients, however, the immunosuppressed state during treatment can cause its own problems, such as when dealing with infections that could normally be fought off by a healthy immune system. This was the case when it came to Rorys unique infection.

In late 2019, Rory was undergoing the final months of treatment for her first SRMA relapse when she began to show unusual symptoms.

Rory came back to the VMTH because she had some issues that didnt really fit SRMA, said Dr. Melissa Andruzzi, the veterinary chief resident at the hospital.

She had seizures and her behavior was very different. Shes normally a really happy-go-lucky kind of dog who loves everyone and wants to lick everyone, but now she was afraid of people and a little bit aggressive toward people she didnt know. It was just very different for her.

Working with veterinary neurologist Dr. Beth Boudreau, a CVMBS assistant professor, Andruzzi scheduled an MRI for Rory and noticed that her brain looked abnormal in some places, another issue not connected to SRMA. She then extracted a sample of spinal fluid and sent it to CVMBS associate professor Dr. Sara Lawhon and graduate assistant Mary Krath at the VMTHs Clinical Microbiology Lab, who found the presence of the Salmonella called enterica subspecies houtenae.

The infection was likely a bacteremia, meaning it had spread in her blood and had access to her whole body, she said. The reason her central nervous system was particularly affected is because its natural barrier (the blood brain barrier) was already compromised from her SRMA, allowing easy access for the Salmonella.

Despite the novel aspects of Rorys case, she was treated much like any other patient with a serious infection with several months of antibiotics. Rorys SRMA was fully cleared by the time she began her Salmonella treatments, allowing her to stop taking the immunosuppressant steroids and fight the infection with her full immune system.

Once Rory was back on the road to full health, only one question remained: How did she become the first dog to contract that form of Salmonella?

After talking to Overhouse, Andruzzi came to the conclusion that wild geckos in her backyard might have been the source of the infection.

This form of Salmonella is most commonly identified in reptiles and amphibians, and more than 90% of reptiles are asymptomatic carriers. They contaminate whatever environment theyre in, Andruzzi said. Rory very commonly interacted with these little geckos outside and in the garage. So while we dont know for sure, we think it probably came from that.

Even after Rory went home healthy and happy, the work was not done for Andruzzi and her coworkers.

After we had treated her so successfully, we thought it was very important to write her case up so that if anyone else saw this type of Salmonella in a dog, or any other Salmonella in a dogs brain or spinal cord, they at least would have Rorys case to read about and see how we treated her, Andruzzi said. We needed to contribute this knowledge so that other veterinarians can treat other pets just as well.

But for Overhouse, the joy from finally seeing her dog healthy outshines all other positive aspects of Rorys case.

Rorys doing really well now. You wouldnt know anything happened to her, Overhouse said. Her veterinary team was great; they seemed to really listen and they were all very caring. I feel like they really had her best interests at heart and I appreciated that very much.

Ive not had many other kinds of dogs besides boxers, so I know theyre very people oriented. Rory follows me everywhere I go, she said. She is definitely connected to me and I to her. Im always looking out for her.

Read the rest here:
Texas A&M Veterinarians Presented With First-Of-Its Kind Case - Texas A&M University Today

Veterinary Medicine Market Research Report by Mode of Delivery (Oral and Parenteral), by Product (Biologics, Medicated Feed Additives, and Pharmaceuticals), by Animal Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Medicine Market Research Report by Mode of Delivery, by Product, by Animal Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06007646/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Veterinary Medicine Market is expected to grow from USD 22.77 Billion in 2019 to USD 34.93 Billion by the end of 2025.2. The Global Veterinary Medicine Market is expected to grow from EUR 20.33 Billion in 2019 to EUR 30.62 Billion by the end of 2025.3. The Global Veterinary Medicine Market is expected to grow from GBP 17.84 Billion in 2019 to GBP 27.22 Billion by the end of 2025.4. The Global Veterinary Medicine Market is expected to grow from JPY 2,482.38 Billion in 2019 to JPY 3,728.21 Billion by the end of 2025.5. The Global Veterinary Medicine Market is expected to grow from AUD 32.76 Billion in 2019 to AUD 50.72 Billion by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Veterinary Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Parenteral is projected to witness the highest growth during the forecast period"

Based on Mode of Delivery, the Veterinary Medicine Market studied across Oral and Parenteral. The Parenteral commanded the largest size in the Veterinary Medicine Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

"The Medicated Feed Additives is projected to witness the highest growth during the forecast period"

Based on Product , the Veterinary Medicine Market studied across Biologics, Medicated Feed Additives, and Pharmaceuticals. The Biologics further studied across DNA Vaccines, Inactivated Vaccines, Live attenuated vaccines, and Recombinant Vaccines. The Pharmaceuticals further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides. The Biologics commanded the largest size in the Veterinary Medicine Market in 2019. On the other hand, the Medicated Feed Additives is expected to grow at the fastest CAGR during the forecast period.

"The Production is projected to witness the highest growth during the forecast period"

Based on Animal Type, the Veterinary Medicine Market studied across Companion and Production. The Companion further studied across Cats, Dogs, and Horses. The Production further studied across Cattle, Fish, Poultry, Sheep & Goats, and Swine. The Companion commanded the largest size in the Veterinary Medicine Market in 2019. On the other hand, the Production is expected to grow at the fastest CAGR during the forecast period.

"The Point-of-care Testing/In-House Testing is projected to witness the highest growth during the forecast period"

Based on End-user, the Veterinary Medicine Market studied across Point-of-care Testing/In-House Testing, Reference Laboratories, and Veterinary Hospitals & Clinics. The Veterinary Hospitals & Clinics commanded the largest size in the Veterinary Medicine Market in 2019. On the other hand, the Point-of-care Testing/In-House Testing is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Veterinary Medicine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Veterinary Medicine Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Medicine Market including Archer-Daniels-Midland Company, Biogenesis Bago SA, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Indian Immunologicals Ltd, Kindred Biosciences, Inc., Merck & Co. Inc., Neogen Corporation, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol S.A., Virbac SA, and Zoetis Inc..

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Medicine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Veterinary Medicine Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Medicine Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Medicine Market?4. What is the competitive strategic window for opportunities in the Global Veterinary Medicine Market?5. What are the technology trends and regulatory frameworks in the Global Veterinary Medicine Market?6. What are the modes and strategic moves considered suitable for entering the Global Veterinary Medicine Market?Read the full report: https://www.reportlinker.com/p06007646/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Story continues

See the article here:
Veterinary Medicine Market Research Report by Mode of Delivery, by Product, by Animal Type, by End-user - Global Forecast to 2025 - Cumulative Impact...

DAVIS, Calif. (KTXL) Three women studying veterinary medicine at the University of California, Davis recently discovered they have a lot more in common than an interest in helping animals.

Their lives are linked by a series of remarkable coincidences stretching all the way from a province in China to the campus of UC Davis.

Molly Mettler, Livvy Peterson and Jennie Furth-Jacobus are all first-year veterinary students. Theyre all left-handed and they all played volleyball in high school. They each grew up in Southern California. In fact, Mettler and Furth-Jacobus lived just 10 minutes from each other in Los Angeles. They never met until they got to UC Davis.

But the bond between the three goes far beyond common interests or characteristics. During a conversation last semester, they realized their life stories coincide on a much deeper level.

We just kind of started talking and introducing ourselves and we got around to talking about how we were all adopted from China. And then we got to, like, Oh, where in China? Peterson said. And we were from the same province: in Guangdong.

And so we really bonded over that, Furth-Jacobus said.

Then we talked more about it, the details of it, Mettler added.

They were each abandoned as infants by their birth parents and placed in orphanages in Guangdong province.

From there, they were all adopted by American parents through the same adoption agency, and never having met, they each pursued veterinary medicine degrees and got accepted into the prestigious program at UC Davis.

Like a What are the odds? kind of thing, Peterson said.

I cant wrap my head around it still, Mettler said.

And then to have us in the first year together in the same class its crazy, Furth-Jacobus said.

In the same lab group too, Mettler added.

Oh yeah, and were in the same lab group, Furth-Jacobus agreed.

Because were divided into four different groups, Mettler said. So the chances of even just being put in the same group too is even slimmed down more.

During a time when lectures are given online for COVID-19 safety, the labs provide that rare space where class is conducted in-person. And thats how the friends really got to know each other.

Weve been very grateful to have in-person labs, Furth-Jacobus said.

Yeah, its something that were definitely not taking for granted, Mettler added.

Especially when we havent really gotten a lot of chances to meet a lot of our classmates. So then having something else that connects you deeper is like, you know, another step, Peterson said. So I think thats really cool.

Clearly, gratitude is also on the list of things the three have in common. That gratitude extends to the parents who adopted them and, with understanding hearts, to the birth parents who surrendered them.

I know that they did their best and that circumstances were just really tough, Furth-Jacobus said.

Its one of those things that was kind of meant to be, Peterson said. Like Im personally really happy that I ended up here in America with my American family that I did.

I mean, were here at UC Davis, the number one vet school in the world. So Im grateful for the sacrifices that they made so that I could have a better life, Furth-Jacobus added.

Thats amazing that were here together and weve experienced that, Mettler said.

The rest is here:
What are the odds?: UC Davis veterinary students discover they were adopted from the same Chinese province - KTXL FOX 40 Sacramento

As the field of veterinary forensics continues to develop, a forensic pathologist at the University of Florida College of Veterinary Medicine has created two programs, A Dog Has No Name and A Cat Has No Name, to investigate the deaths of unclaimed dogs and cats. At the same time, the International Veterinary Forensic Sciences Association has released standards for postmortem examinations.

Dr. Adam Stern, a forensic pathologist at the UF veterinary college, created the new programs to investigate the deaths of unclaimed animals in the Florida area. Since the programs start in 2019, more than 150 dogs and cats have been examined, including some from across the U.S.

Were doing a long-term mortality study, looking at these animals and figuring out what is going on with them, Dr. Stern said. Theyre not all being hit by cars, and we are finding some interesting stuff. We are documenting it, including some suspicious deaths that we report to law enforcement.

A Dog Has No Name and A Cat Has No Name are a collaboration between law enforcement and forensic specialists at Floridas Maples Center for Forensic Medicine.

One of the goals of the programs is to find the owners of the unclaimed animals.

We have reunited some dogs to the owners for closure, and they were appreciative for what we did. Its doing a good deed, at the end of the day. Some of these people are going to be searching for a dog forever. We want to provide closure, Dr. Stern said. As a pathologist, I deal with end of life, that is all I do. This is a positive effect, the closure is positive.

Dr. Stern said the programs are also being used to train residents and students on death investigations. Most case investigations include a traditional autopsy and a gross examination with a postmortem CT scan and radiography.

Anything we need to do, we will do, Dr. Stern said. If we have an owner that thinks it may be their cat, we have the capabilities to do a DNA comparison. We are also banking tissues from every case. We have reports from every case that include tissues, so we can go back and do retrospectives.

Dr. Stern is also working to make other veterinarians across the U.S. aware of what the programs do and is currently willing to accept samples of unowned, stray, or street animals from anywhere in the U.S. The services are free of charge.

The guidelines on postmortem examinations, released in December 2020, include clinical best practices for identifying, documenting, and preserving evidence in crimes when animals are involved and there is suspected abuse.

The guidelines (PDF) were created by the International Veterinary Forensic Sciences Association.

As board-certified pathologists and leaders in the field of veterinary forensic pathology, it is our duty to develop a set of standards to provide a framework to ensure that forensic postmortem examinations are performed to a minimum standard, Dr. Stern said.

The standards include some of the following language related to how a veterinarian should perform a postmortem examination:

Correction: An earlier version of this article incorrectly stated the organization that created and published the guidelines on postmortem examinations. International Veterinary Forensic Sciences Association created the guidelines.

Continued here:
New forensic programs investigate deaths of unclaimed dogs and cats - American Veterinary Medical Association

Event

Virtual business meeting, Sept. 26, 2020

Career Achievement AwardDr. Peter Pascoe, Davis, California. A 1975 veterinary graduate of the University of Liverpool in England, Dr. Pascoe is a professor emeritus of surgical and radiological sciences at the University of California-Davis. He helped launch the journal Veterinary Anesthesia and Analgesia and served as its editor until 2013, remaining on the editorial board. Dr. Pascoe is a diplomate of the ACVAA and the European College of Veterinary Anaesthesia and Analgesia.

Presidents AwardDrs. John Ludders (Washington State 77), Spokane, Washington, and Pauline Wong (California-Davis 75), San Diego, were recognized for their work in creating and maintaining the ACVAA Listservs. A diplomate of the ACVAA, Dr. Ludders is a professor emeritus in the section of anesthesiology at Cornell University College of Veterinary Medicine. Dr. Wong served as a lecturer and was a consulting anesthesiologist at the University of California-Davis School of Veterinary Medicine prior to retirement. She is a diplomate of the ACVAA.

Lisa Ann Bourazak, Highland Park, IllinoisAngie Lagos Carvajal, Calgary, AlbertaUrshulaa Dholakia, New Hyde Park, New YorkBen Gingold, New York CityAlison Jaeger, Davis, CaliforniaEmma Kate Johnson, Roseville Chase, AustraliaGenevive Caterina Luca, San Jose, CaliforniaMatthew Milloway, ChicagoMelissa Murdock, PhiladelphiaTania Perez Jimenez, Pullman, WashingtonFrdrik Rousseau-Blass, Sainte-Hyacinthe, QuebecDanielle Eliese Strahl-Heldreth, Champaign, IllinoisChristopher Thibault, Lansing, MichiganEduardo Uquillas, Elderslie, AustraliaKelley Varner, Columbia, Missouri

The association discussed problems caused by the ongoing COVID-19 pandemic, including the postponement of the 2020 certifying examination, which was subsequently held remotely in October, and the effect on residency programs and resident training.

Drs. Colin Dunlop, Gladesville, Australia, president; Kurt Grimm, Conifer, Colorado, president-elect; Lynne Kushner, Portsmouth, Rhode Island, executive secretary; Berit Fischer, Lebanon, New Jersey, chair of the board of directors; and Christine Egger, Saskatoon, Saskatchewan, immediate past president

View post:
American College of Veterinary Anesthesia and Analgesia - American Veterinary Medical Association

Latest Study on Industrial Growth ofGlobal Veterinary Medicine Market2019-2025. A detailed study accumulated to offerLatest insights about acute features of the Veterinary Medicine market. The report contains different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis.

The Major Players Covered in this Report: Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell

Veterinary Medicine Market Study guarantees you to remain / stay advised higher than your competition. With Structured tables and figures examining the Veterinary Medicine, the research document provides you a leading product, submarkets, revenue size and forecast to 2025. Comparatively is also classifies emerging as well as leaders in the industry.Click To get SAMPLE PDF (Including Full TOC, Table & Figures)

Global Veterinary Medicine market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Veterinary Medicine.

This report researches the worldwide Veterinary Medicine market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.This study categorizes the global Veterinary Medicine breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

This study also covers company profiling, specifications and product picture, sales, market share and contact information of various regional, international and local vendors of Global Veterinary Medicine Market. The market opposition is frequently developing greater with the rise in scientific innovation and M&A activities in the industry. Additionally, many local and regional vendors are offering specific application products for varied end-users. The new merchant applicants in the market are finding it hard to compete with the international vendors based on reliability, quality and modernism in technology.

Global Veterinary Medicine market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Veterinary Medicine.

This report researches the worldwide Veterinary Medicine market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.This study categorizes the global Veterinary Medicine breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

Read Detailed Index of full Research Study at @https://www.htfmarketreport.com/reports/1529343-global-veterinary-medicine-market-2

The titled segments and sub-section of the market are illuminated below:

In-depth analysis of Global Veterinary Medicine market segments by Types: , Oral, Injection & Other

Detailed analysis of Global Veterinary Medicine market segments by Applications: Companion Animals & Livestock Animals

Major Key Players of the Market: Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell

Regional Analysis for Global Veterinary Medicine Market: APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) North America (U.S., Canada, and Mexico) South America (Brazil, Chile, Argentina, Rest of South America) MEA (Saudi Arabia, UAE, South Africa)

Furthermore, the years considered for the study are as follows:Historical year 2014-2019Base year 2019Forecast period** 2020 to 2025 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Buy Latest COVID Impact Study of Global Veterinary Medicine Market @https://www.htfmarketreport.com/buy-now?format=1&report=1529343

Guidance of the Global Veterinary Medicine market report:

Detailed considerate of Veterinary Medicine market-particular drivers, Trends, constraints, Restraints, Opportunities and major micro markets. Comprehensive valuation of all prospects and threat in the Global Veterinary Medicine market. In depth study of industry strategies for growth of the Veterinary Medicine market-leading players. Veterinary Medicine market latest innovations and major procedures. Favorable dip inside Vigorous high-tech and market latest trends remarkable the Market. Conclusive study about the growth conspiracy of Veterinary Medicine market for forthcoming years.

What to Expect from this Report On Veterinary Medicine Market:

1. A comprehensive summary of several area distributions and the summary types of popular products in the Veterinary Medicine Market.2. You can fix up the growing databases for your industry when you have info on the cost of the production, cost of the products, and cost of the production for the next future years.3. Thorough Evaluation the break-in for new companies who want to enter the Veterinary Medicine Market.4. Exactly how do the most important companies and mid-level companies make income within the Market?5. Complete research on the overall development within the Veterinary Medicine Market that helps you elect the product launch and overhaul growths.

Enquire for customization in Report @https://www.htfmarketreport.com/enquiry-before-buy/1529343-global-veterinary-medicine-market-2

Detailed TOC of Veterinary Medicine Market Research Report-

Veterinary Medicine Introduction and Market Overview Veterinary Medicine Market, by Application [Companion Animals & Livestock Animals]

Veterinary Medicine Industry Chain Analysis Veterinary Medicine Market, by Type [, Oral, Injection & Other]

Industry Manufacture, Consumption, Export, Import by Regions (2014-2019) Industry Value ($) by Region (2014-2019)

Veterinary Medicine Market Status and SWOT Analysis by Regions

Major Region of Veterinary Medicine Marketi) Global Veterinary Medicine Salesii) Global Veterinary Medicine Revenue & market share Major Companies List Conclusion

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]report.com

Connect with us atLinkedIn|Facebook|Twitter

https://neighborwebsj.com/

Continued here:
Veterinary Medicine Market to Witness Huge Growth by 2026 | Bayer Animal Health, Merck Animal Health, Virbac - NeighborWebSJ

Every person in the world has been impacted by the COVID-19 pandemic in at least one way over the past year. Humans, however, are not the only species affected by the virus and its ability to separate families.

On New Years Eve, a Knoxville resident contracted COVID-19 and had to be hospitalized. Although he was used to having his assistance dog, Duchess, by his side at all times, he needed to find someone to take care of his beloved pet while he was treated at UT Medical Center. Luckily, a UT program was able to help.

A part of the UTs College of Veterinary Medicine, the Program for Pet Health Equity is designed to ensure that all pets have access to veterinary care.

Dr. Michael Blackwell, the director of the Program for Pet Health Equity and the Center for Behavioral Health Research in the College of Social Work, wants to be sure that all pets have healthcare readily available to them because pets are so important to families in the United States.

We are addressing a national family crisis in America, Blackwell said. Two thirds of households in America have pets and 88% of those families consider their pet a family member.

We dont have a network of healthcare that subsidizes healthcare of nonhuman members. Our work is really about addressing that national crisis. This is about more than just pets. Its about American families.

One of the ways the Program for Pet Health Equity aims to execute their mission is by using the program Aligncare, which uses veterinary social workers to help citizens find resources for their pets.

Dr. Pamela Linden, Director of Veterinary Social Work for the Aligncare program, is also passionate about finding community resources for pet-owners to use when they may not be able to afford veterinary care.

It's not unusual for people to find themselves in situations where they need assistance and there are very few organized systems to assist pet owners with life circumstances, Linden said.

People end up being unexpectedly hospitalized, people get sick, people move, people pass away and they have pets.

These are all life situations that have the potential to separate families or people from their beloved pets. So, we at Aligncare are very interested in helping communities create systems that are planful to help keep families together, Linden said.

This organized system is what came to the rescue when Duchess needed help on New Years Eve. Not only did Duchess need a place to stay, but she also has cancer, so she needed someone to properly administer her medication while she was separated from her owner.

When Dr. Linden heard about the situation, she immediately contacted Knoxville Animal Control, who were quick to help.

We have the relationship with the client, so the client reached out and then our partners in Knoxville really stepped up to the plate and made sure that this family got what they needed to stay together, Linden said.

Their idea was to get Duchess to Young Williams Animal Center, but seeing as it was a holiday, the center was closed. After working it out with UT Medical Center, they eventually were able to contact the shelter who watched Duchess over the long weekend. Also, a key player in the events was Central Veterinary Hospital, who ensured that Duchesss medication was not interrupted.

After the holiday weekend, the client recovered and was reunited with Duchess. The events on New Years Eve are a prime example of how a community can work together to ensure that citizens have the proper resources to care for their animals.

The best way to say it is everybody came together and went above and beyond what would normally be expected, and the client is so grateful for the assistance of everyone who came together to help him and Dutchess, Linden said.

Its a wonderful story because not only does it shine a light on Aligncare, it shines a light on Knoxville, because there were multiple partners involved and to see people step up to the plate and address a critical need for one of our citizens is what we want to see going on in all communities in America, Blackwell said.

Created at UT, the Veterinary Social Work program combines the principles of both social work and veterinary medicine to create a field that focuses on bridging the gap between human and animal needs. The intersection of these two disciplines is to thank for the care that Duchess and her owner received on New Years Eve.

Duchesss story is a positive reminder of the good that can come when people join forces to help each other, and its a story that people need to hear, especially right now.

We need to see the good side of America because theres so much going on in the nation, Blackwell said. We get to hear about the frontline medical workers and the frontline workers in other places, but throughout America, were still made up of a lot of compassionate, caring people, and whatever we do we need stories that remind us that that's us too a caring, compassionate nation.

Aligncare also has community sites in Las Vegas, Phoenix, Asheville, N.C. and Long Island, N.Y. They have student interns from multiple universities including UT, NYU, Stony Brook University and St. Josephs College.

Read the rest here:
UT's Aligncare Program works with Knoxville organizations to help COVID-19 patient and his assistance dog on New Year's Eve - UT Daily Beacon

DAVIS, Calif. (KTXL) Three women studying veterinary medicine at the University of California, Davis recently discovered they have a lot more in common than an interest in helping animals.

Molly Mettler, Livvy Peterson and Jennie Furth-Jacobus are all first-year veterinary students. Theyre all left-handed and they all played volleyball in high school. They each grew up in Southern California.

In fact, Mettler and Furth-Jacobus lived just 10 minutes from each other in Los Angeles. They never met until they got to UC Davis.

But during a conversation last semester, they realized their lives are linked by a series of coincidences stretching all the way from a province in China.

We just kind of started talking and introducing ourselves and we got around to talking about how we were all adopted from China. And then we got to, like, Oh, where in China? Peterson said. And we were from the same province: in Guangdong.

And so we really bonded over that, Furth-Jacobus said.

Then we talked more about it, the details of it, Mettler added.

They were each abandoned as infants by their birth parents and placed in orphanages in Guangdong province.

From there, they were all adopted by American parents through the same adoption agency. They each pursued veterinary medicine degrees and got accepted into the prestigious program at UC Davis.

Like, what-are-the-odds kind of thing, Peterson said.

I cant wrap my head around it still, Mettler said.

And then to have us in the first year together in the same class its crazy, Furth-Jacobus said.

In the same lab group, too, Mettler added.

Oh yeah, and were in the same lab group, Furth-Jacobus agreed.

Because were divided into four different groups, Mettler said. So the chances of even just being put in the same group, too, is even slimmed down more.

During a time when lectures are given online for COVID-19 safety, the labs provide that rare space where class is conducted in-person. And thats how the friends really got to know each other.

Weve been very grateful to have in-person labs, Furth-Jacobus said.

Yeah, its something that were definitely not taking for granted, Mettler added.

Especially when we havent really gotten a lot of chances to meet a lot of our classmates. So then having something else that connects you deeper is like, you know, another step, Peterson said. So I think thats really cool.

Gratitude is also something they have in common extending to the parents who adopted them as well as to the birth parents who surrendered them.

I know that they did their best and that circumstances were just really tough, Furth-Jacobus said.

Its one of those things that was kind of meant to be, Peterson said. Like Im personally really happy that I ended up here in America with my American family that I did.

I mean, were here at UC Davis, the No. 1 vet school in the world. So Im grateful for the sacrifices that they made so that I could have a better life, Furth-Jacobus added.

Thats amazing that were here together, and weve experienced that, Mettler said.

Link:
What are the odds?: 3 UC Davis students discover they were adopted from same Chinese province - WGN TV Chicago

Getting back to basics might be the key to keeping the largest portion of the horses GI tract functioning properly

Horses are powerful, athletic animals. Their digestive systems, however, are delicate compared to those of most other types of livestock. Ruminants such as cattle and sheep have multicompartment stomachs. Saliva created by chewing a cud processes food in the front half of ruminants digestive tracts. Horses, however, rely on a metabolically complex fermentation process. And because horses only have one stomach, most of that fermentation occurs in the back part or hindgut.

Despite making up the largest portion of a horses gastrointestinal (GI) tract, the hindgut, which includes the cecum and large colon (or large intestine), often receives far less attention from owners than the stomach or small intestine, says Kenneth Kopp, DVM, a consulting veterinarian based in St. Louis, Missouri.

The hindgut is about 25 gallons in a 1,000-pound horsethats huge compared to the (2-4-gallon) stomach, he says. The stomach is only 10% of the GI tract, but theres such a focus there. Billions of microorganisms, including protozoa, fungi, and bacteria, live in the hindgut. Their job is to convert carbohydrates into fatty acids and provide the horse with energy. Feed or forage might spend as much as 48 hours in the hindgut compared to a few hours or less in the small intestine.

Ideally, by the time material gets to the hindgut, water-soluble carbohydrates and easily digestible proteins are already broken down and absorbed, says Amy Biddle, PhD, assistant professor of animal science in the University of Delawares Department of Animal and Food Sciences, in Newark. The fibrous part of feed, structural carbohydrates, are passed right through the small intestine to the hindgut, where the bacteria are really good at breaking them down and converting them to energy sources that the horse can utilize.

The hindgut also absorbs short-chain fatty acids, which Biddle estimates provide at least 46% of the horses energy stores. For that and other reasons it is critical to keep those microorganisms happy and functioning properly.

Although researchers, veterinarians, and nutritionists know how critical hindgut function is to overall health, they know much less about this part of the digestive system than others. Generally, theyre unable to examine the hindgut with imaging equipment, and clinicians dont perform autopsies in horses as frequently as they do in food animals. Veterinarians can use ultrasound to see small portions of the hindgut through the abdominal wall, and they can reach the colon with a GI smart pill endoscopic camera, but visibility is still limited. For the most part, researchers look to studies in humans and other livestock species and existing equine digestive system research to help horse owners promote a healthy hindgut.

The hindgut is naturally more basic than other parts of the digestive system, says Biddle. Large grain meals and sudden diet changes can promote the growth of lactic acid producers that rapidly shift the pH level in the hindgut and can lead to lactic acidosis, a dangerous situation in which the acidity increase kills off the beneficial bacterial population.

This is why it is important to change feeds so slowly, so the microbes in the hindgut can keep up, says Biddle, and so abrupt changes do not stress the system. Especially if youre going to change to a diet higher in nonstructural carbohydrates (simple sugars and fructans, which are readily digested), it has to be introduced slowly.

Getting back to basics and simplifying meals is the best approach for maintaining a healthy hindgut. Ideally, you want to feed your horse a diet thats high in forage and low in grains, says Anthony Blikslager, DVM, PhD, Dipl. ACVS, head of the department of clinical sciences and equine surgery and gastroenterology professor at North Carolina State Universitys College of Veterinary Medicine, in Raleigh.

Horses evolved on ever-changing marginal grasslands. They were browsers that adapted to be grazers that rely on continual forage intake. This article continues in the February 2021 issue of The Horse: Your Guide to Equine Health Care. Subscribe now and get an immediate download of the issue to continue reading. Current magazine subscribers can access the digital edition here.

See the original post here:
Keeping the Horse's Hindgut Happy The Horse - TheHorse.com

The first Americans started receiving the COVID-19 vaccines in mid-December. By late January, however, many veterinarians still werent sure where they were in the line for vaccination.

The AVMA House of Delegates, during its regular winter session in early January, discussed the COVID-19 pandemic during the Veterinary Information Forum, and many delegates focused on the rollout of vaccines across the country.

The AVMA has successfully advocated for veterinarians to be among those prioritized for vaccination in federal-level guidance, but tactical decisions are made at the state, territorial, and local levelsand the situation continues to evolve.

Other delegates touched on ongoing difficulties with providing child care during the pandemic.

Dr. Cheryl Greenacre, delegate for the Association of Avian Veterinarians, started the discussion by asking what state VMAs can do to advocate so that veterinarians will be listed as health care workers able to receive COVID-19 vaccines in Phase 1a.

Dr. Jos Arce, AVMA president-elect, said the AVMA has been advocating for veterinarians to be a priority group since September. The AVMA provided comments to the National Academies of Sciences, Engineering, and Medicine on the Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. The draft was intended to inform the Centers for Disease Control and Preventions Vaccination Program Interim Playbook for Jurisdiction Operations.

In Puerto Rico, where Dr. Arce lives, the territorys veterinary association met with the territorys health department and other health associations and, later, the National Guard. Veterinarians thought they were going to be in Phase 1b, as front-line essential workers, and they were surprised to be scheduled for late 1a. Dr. Arce suggested that state VMAs should contact the state health department and join with other health professions.

Dr. Carol Ryan, Missouri delegate, said veterinarians are scheduled for Phase 1b in Missouri. As of early January, no veterinarians or veterinary staff members had been able to be immunized. She was curious whether, in other states, staff members were included with veterinarians as a priority group.

In Puerto Rico, Dr. Arce replied, everyone on the veterinary team qualifies for the same phase. Veterinarians need to provide their license to practice and a form proving that a staff member works at a veterinary hospital.

Dr. Diana Thom, Washington state delegate, said the Washington State VMA sent out a notification in early January that the state had added a catchall in Phase 1a to cover all health care workers. The WSVMA interpreted that to mean veterinarians and their teams. After the House of Delegates session, the WSVMA issued an update saying health officials subsequently told the association that veterinarians were in a later phase to be determined.

Dr. Jon Pennell, Nevada delegate, said the Nevada VMA and state veterinary board submitted a letter requesting that veterinarians be included in one of the earlier tiers for vaccination. Dr. William Grant, California delegate, said he had just heard the good news that the California Department of Public Health had designated veterinarians and veterinary staff members to be in Phase 1a.

The AVMA comments to the National Academies used the following rationale:

The AVMA has developed a downloadable poster for the back office, Fighting COVID-19 starts with you, to encourage all team members to get vaccinated as early as possible.

The AVMA also has developed a list of answers to frequently asked questions about vaccination against COVID-19.

One question is, Can practice owners require team members to be vaccinated against COVID-19 when a vaccine is available to them?

The answer states that, according to guidance from the U.S. Equal Employment Opportunity Commission: Employers may, under certain conditions, bar employees from the workplace if they refuse to get a vaccine. ... The EEOC warns, however, that this does not mean the employer may automatically terminate the employee. ... For example, the employee may be entitled to an accommodation, such as performing work remotely. ... State law may differ from federal law and may prohibit employers from requiring employees to receive a COVID-19 vaccination.

As the vaccine rollout continues, working parents at veterinary practices and elsewhere continue to juggle doing their jobs with caring for young children as many schools and day cares remain closed.

Dr. Paul Toniolli, Utah alternate delegate, said his office manager started to work from home. Hes had children come into the clinic, which is not ideal, but the building has an upstairs area. Some staff members have to stay home to watch their kids. He has stepped up the pace himself, working extra hours, and is simply being more flexible.

Dr. Lindy ONeal, Arkansas delegate, said that as her two-clinic practice is continuing with curbside service, some examination rooms are not being used. The practice allows staff members to bring children in to have a place for them to go. One of the clinics even has a napping room. Children are not allowed to come if they are under quarantine, but using the empty examination rooms has been a creative way to be flexible.

Read the rest here:
When will veterinarians get COVID-19 vaccines? - American Veterinary Medical Association

Veterinarians, microbiologists and epidemiologists are testing pets, farm animals and wildlife to see if they can pass COVID-19 mutations to humans

COLUMBUS, Ohio While much effort is currently invested in understanding how COVID-19 (SARS-CoV-2) spreads among and infects humans, researchers at The Ohio State University are focusing on better understanding how the virus might arise and mutate in animal populations, and in turn impact humans.

Dr. Vanessa L. Hale, assistant professor of veterinary preventive medicine at The Ohio State University College of Veterinary Medicine, alongside peers from the Infectious Disease Institute and Center of Microbiome Science, is coordinating the efforts of investigators across various departments and colleges at Ohio State.

Were seeing that its not good enough to just respond to a pandemic. We need to be prepared for it in terms of strategies and logistics and understand the science behind animal to human and human to animal disease transmission, Hale said.

We spend a lot of time understanding how the disease transmits within humans, and now we are taking a step back to examine if animals can carry the virus, if they get sick and whether they can re-infect humans. Finding the answers to these questions will help predict and prevent future infections.

The University-wide program including veterinarians, microbiologists and epidemiologists is known as eSCOUT: Environmental Surveillance for COVID-19 in Ohio: Understanding Transmission. Together, these experts are testing pets, farm animals and wildlife and examining samples in the lab.

The goal is to identify whether the virus exists in different animal populations and the likelihood that those animals could harbor mutations and potentially pass COVID-19 back to humans in a new form.

Identifying SARS-CoV-2 in animals can help to start answering questions about what kinds of animals can be infected, symptomatically or asymptomatically, and if these animals can then transmit the virus to other animals or people. Environmental and animal surveillance will provide critical insights on current circulating SARS-CoV-2 strains as well as emerging mutations and spread. This monitoring is vital to help predict and prevent future outbreaks and spillover events.

eSCOUT is also involved in testing wastewater and storm water (also referred to as urban runoff) around Ohio for SARS-CoV-2. Researches say that identifying the virus in wastewater can help determine how much and what strain of virus is circulating within a population. Viral spikes in wastewater also allow early detection of outbreaks.

Pandemics really highlight one health, which is human health, animal health and environmental health. Veterinarians, as well as environmental microbiologists, wildlife biologists and epidemiologists are really essential to understanding the whole dynamic of a pandemic, Hale said.

Environmental surveillance has been used in the past to identify new strains of the flu that could potentially spillover from animals to humans. Its likely that this same kind of surveillance will play a critical role in mitigating the COVID-19 pandemic as well as long-term preventive efforts.

The rest is here:
Researchers at Ohio State University are studying COVID-19 in animals and the environment to identify future pandemic threats - WKYC.com

Thanos Tzempelikos, professor in the Lyles School of Civil Engineering, has received the prestigious Leon Gaster Award from the Society of Light and Lighting as a co-author of the paper, "Cross-validation and Robustness of Daylight Glare Metrics." This award is presented annually, naming the best paper of the year concerned with lighting applications. The award was presented at the societys Annual Awards evening in December in London.

Dr. David Waters is the recipient of the Center on Aging and the Life Course's (CALC) Outstanding Professor Award.Waters is professor emeritus in the College of Veterinary Medicine and a CALC faculty associate. Waters teaches biology of aging and received numerous student nominations for the award, which recognizesexceptional teaching and mentoring of emerging scholars in aging. He is director of the Center for Exceptional Longevity Studies at the Gerald P. Murphy Cancer Foundation.

* * * * *

Orr Fellowship, a postgraduate professional development program based in Indianapolis, has recently selected four Purdue seniors as Orr Fellows. The Orr Fellowship is one of Indianas most celebrated nonprofit talent programs. The students Miguel Diaz, Sean ODell, Eleanor Hamilton and Hannah Vanderbosch were chosen out of nearly 1,300 applicants and will begin at one of 46 Orr Fellowship partner companies upon graduating in May. They also will participate in Orr Fellowship programming dedicated to nurturing entrepreneurship and developing strong leadership skills.

Christine McCall, a graduate research and teaching assistant in the College of Health and Human Sciences, earned a top honor from the National Council on Family Relations for a paper. McCall won the Outstanding Student and New Professional Paper Award for her paper titled A Part of Our Family? Effects of Psychiatric Service Dogs on Quality of Life and Relationship Functioning in Military-Connected Couples.

Read more:
Appointments, honors and activities - Purdue News Service

Hemp Feed Coalition announces the first submission for hemp to become an approved animal feed ingredient.

"The coalition has worked hard over the last two years and we are finally getting our first steps behind us in the world of federal approval; something that most every day Americans would be shocked to know is so heavily regulated. HFC doesn't just represent the hemp industry but all the farmers and ranchers out there that deserve the opportunity to monetize their efforts and compete on the global market of industrial hemp." - Morgan Elliott, Co-Founder of IND HEMP.

Now that the first application has been submitted, the HFC will turn its focus to research on other hemp by-products: oil, sediment, hulls, pulp and screenings to investigate their benefit and safety as feed ingredients. In addition, this work will include the clinical trials necessary to add ruminates to the hempseed meal application that was submitted. "Opening new markets is our secondary mission," said Buffington "Commoditizing safe and healthy by-products from hemp processing will provide farmer and processor revenue and a build a steady supply as the industry matures in the next few years." The HFC will be leading those efforts by bringing researchers, hemp and feed industry experts and coalition advisors together for additional applications and Federal regulatory approval for new hemp ingredients as feed for animals.

The Hemp Feed Coalition (HFC) began in 2018 as a pilot project under the Colorado Hemp Industries Association (COHIA) before forming its own non-profit organization in 2020. The HFC intends to continue its mission to gain federal approval for additional hemp by-products as commercial animal feed. To support the work of the HFC, visit our websiteand become a member. Members receive discounts, special offers, invitations and member only communications. For more information on current research and ingredient data collection contact Hunter Buffington at [emailprotected]

Press release supported by New West Genetics, Inc.

SOURCE Hemp Feed Coalition

Go here to see the original:
Hemp Feed Coalition submits the first ingredient application in the United States for hemp to be federally approved as a feed ingredient for poultry -...

Brook Toussaint had to have emergency surgery to have her leg amputated after the bite.

CORPUS CHRISTI, Texas Surviving a shark attack puts you in an elite class with an incredible tale to tell. One Corpus Christi native has one of those harrowing stories.

Brook Toussaint has always been an animal lover, her family said.

When she wasn't busy adoring animals, Brook spent her time in the water as a lifeguard and on a swim team.

Combine those two passions, and her sister Paige said it should not come as a surprise that Brook loved marine life.

"I can safely say she's an animal lover," Paige said. "Dolphins have always been her favorite animal, so she's always been attracted to the sea."

Brook was so attracted to sea life that she spent seven years as a volunteer for the Texas Sealife Center and is currently pursuing a degree in Veterinary Medicine at a university on an island in the Caribbean.

But it was one day back in January when Brook's life changed forever. Brook went for a swim with some friends off the coast of an island in the Caribbean when she felt something bit her leg.

"It turns out it was a tiger shark and my sister bravely fought it off," Paige said. "She literally punched it in its nose and gouged its eyes to get it to let go of her leg."

The quick thinking and bravery of Brook and others helped save her life. After having emergency surgery, she had to have her leg amputated.

The life-saving care has come at an enormous cost.

"And then the hospital stays and the rehab, it's adding up very quickly," Paige said.

Brook's family has set up a GoFundMe for the medical expenses. Their goal is $250,000, but with the support of the Coastal Bend community and beyond, they have already raised over $80,000.

For the latest updates on coronavirus in the Coastal Bend, click here.

More from 3News on KIIITV.com:

See the original post:
A Corpus Christi native survived a shark attack in the Caribbean. Here's how you can help. - KIIITV.com